Detail View

ANTI-CD24 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USE THEREOF
Citations

WEB OF SCIENCE

Citations

SCOPUS

Metadata Downloads

DC Field Value Language
dc.contributor.author 예경무 -
dc.contributor.author 신상희 -
dc.contributor.author 신지원 -
dc.date.accessioned 2025-07-31T16:10:13Z -
dc.date.available 2025-07-31T16:10:13Z -
dc.identifier.uri https://scholar.dgist.ac.kr/handle/20.500.11750/58831 -
dc.description.abstract The present invention relates to a novel anti-CD24 antibody and use thereof. The CD24-specific antibody according to one aspect increases phagocytosis activity of macrophages in tumor tissues, and thus can be used as a universal anticancer agent for effectively preventing or treating various cancers associated with CD24 without being limited to carcinomas, and has high binding affinity to both humans and mice, and thus can be clinically and preclinically used. -
dc.title ANTI-CD24 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USE THEREOF -
dc.title.alternative Anti-CD24 antibody or antigen-binding fragment thereof, and use thereof -
dc.type Patent -
dc.publisher.country UN -
dc.identifier.patentApplicationNumber PCT/KR2024/015109 -
dc.date.application 2024-10-04 -
dc.identifier.patentRegistrationNumber 2025075440 -
dc.date.registration 2025-04-10 -
dc.contributor.assignee DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY,재단법인대구경북과학기술원 -
dc.type.iprs 특허 -
Show Simple Item Record

File Downloads

  • There are no files associated with this item.

공유

qrcode
공유하기

Related Researcher

예경무
Yea, Kyungmoo예경무

Department of New Biology

read more

Total Views & Downloads